News | Artificial Intelligence | November 25, 2025

Partnership expands U.S. access to Avicenna’s advanced imaging AI solutions through Ferrum’s AI Governance Suite. Avicenna.AI will be attending RSNA 2025.

Avicenna.AI, Ferrum Health Partner to Expand U.S. Access to Advanced Medical Imaging AI

Nov. 25, 2025  Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI Governance Suite supporting more than 50 industry-leading algorithms. Under the agreement, Ferrum will now commercialize Avicenna.AI’s full portfolio of imaging AI solutions across the United States.

Ferrum’s suite gives clinicians access to advanced AI technologies designed to enhance diagnostic accuracy across oncology, women’s and men’s health, cardiovascular care, neurology, orthopedics and more. By adding Avicenna’s emergency and high-impact imaging solutions to its expanding library, Ferrum strengthens its position as one of the most comprehensive AI marketplaces in healthcare.

Avicenna.AI delivers a full suite of deep learning solutions designed to detect, identify, and quantify life-threatening conditions from CT imaging. Its CINA solutions support radiologists by accelerating the detection of critical findings, prioritizing urgent cases, enhancing workflow efficiency, and improving patient outcomes.

The portfolio includes AI solutions for:

  • Intracranial hemorrhage (CINA-ICH)
  • Large vessel occlusion (CINA-LVO)
  • Aortic dissection (CINA-AD)
  • Pulmonary embolism (CINA-PE and CINA-iPE)
  • Vertebral compression fractures (CINA-VCF)
  • Cervical spine fractures (CINA-CSpine)
  • ASPECT scoring for stroke severity (CINA-ASPECTS)

Ferrum’s platform allows clinicians to validate AI performance on local datasets and integrate AI directly into existing workflows - without protected health information (PHI) ever leaving the health system’s firewall.

“Radiologists and clinicians are asking for AI that truly moves the needle for patients,” said Pelu Tran, CEO of Ferrum Health. “Partnering with Avicenna.AI lets us put some of the most trusted emergency imaging tools directly into the hands of the health systems we serve, expanding access to life-saving technology across the U.S.”

“Our mission is to make high-performance, clinically proven AI accessible to as many clinicians as possible,” said Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “Ferrum’s enterprise-ready platform is the ideal partner to accelerate U.S. adoption and ensure our solutions are deployed safely, efficiently, and at scale.”

Avicenna.AI will be attending RSNA 2025 with a strong presence throughout the show, offering demonstrations and presentations alongside multiple partners. To book a meeting with the company, visit: https://meetings-eu1.hubspot.com/martijn-jonkers/rsna-2025-meet-with-avicennaai


Related Content

News | X-Ray

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an ...

Time July 14, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
Subscribe Now